Porphyromonas gingivalis is a keystone pathogen of chronic periodontitis, and its intraoral levels have been shown to predict disease progression (activity). An accurate and sensitive chair-side (point of care) test to determine disease activity is critical for early intervention and clinical management of disease. This study aimed to develop a rapid, chair-side, saliva-based detection of P. gingivalis. Monoclonal antibodies (mAbs) to the A1-adhesin domain of the P. gingivalis RgpA-Kgp proteinase-adhesin complex were screened by enzyme-linked immunosorbent assay and microbial flow cytometry, with 2 mAbs shown to recognize all laboratory and clinical strains tested, without significantly cross-reacting with other oral bacteria tested. With these mAbs, an immunochromatographic device was produced and shown in preclinical studies to detect, in inoculated saliva, all P. gingivalis laboratory strains and clinical isolates tested. The device was able to detect ≥1 × 10 5 P. gingivalis cells/mL. In a patient age-and sex-matched control clinical cohort, P. gingivalis levels in saliva-as measured by real-time polymerase chain reaction-positively correlated with P. gingivalis levels in subgingival plaque (r = 0.819, P < 0.01) and clinical parameters of disease (r = 0.633, P < 0.01). A positive device result strongly correlated with P. gingivalis levels >1 × 10 5 cells/ mL in saliva (r = 0.778, P < 0.001) and subgingival plaque (r = 0.715, P < 0.001) with sensitivity, specificity, positive/negative predictive values, and accuracy levels of 95.0%, 93.3%, 90.5%, 96.6%, and 94.0%, respectively. The device result also positively correlated (r = 0.695, P < 0.01) with disease severity as measured by probing depth. Detection of P. gingivalis in saliva was found to be rapid, taking 3 min from sample collection.
Introduction
Chronic periodontitis (CP) is a major public health problem in all societies and is estimated to affect 47% of the adult (≥30 y) US population, with 38% having moderate or severe disease (Eke et al. 2012) . Diagnosis of disease activity is critical in disease management. However, conventional clinical indices used to define periodontal cases, such as probing depth (PD), clinical attachment loss (CAL), and bleeding on probing (BOP), are poor predictors of disease progression (i.e., activity; Byrne et al. 2009; Savage et al. 2009 ). Changes in the microbial composition of subgingival plaque have been demonstrated to be associated with disease prevalence or severity (Socransky et al. 1998; Byrne et al. 2009 ). Three subgingival plaque bacteria-Treponema denticola, Tannerella forsythia, and in particular, Porphyromonas gingivalis-have been found to be closely associated with severe forms of disease (Socransky et al. 1998; Byrne et al. 2009; Hong et al. 2015; Kirst et al. 2015) . Increases in P. gingivalis and T. denticola in subgingival plaque have been shown to predict disease progression 3 mo before clinical detection by PD and/or CAL (Byrne et al. 2009 ). The RgpA-Kgp proteinase-adhesin complex is a major P. gingivalis virulence factor and is upregulated in active sites (O'Brien-Simpson et al. 2003; Yost et al. 2015) . RgpA-Kgp complex proteinase activity is a defining P. gingivalis phenotype, and we recently showed that the RgpA/Kgp A1-adhesin domains are highly conserved across all laboratory and clinical P. gingivalis strains investigated (O'Brien-Simpson et al. 2003) . Furthermore, as part of the RgpA-Kgp complex, the A1-adhesin resides on the cell surface, outer membrane vesicles (OMVs) and is antibody accessible (O'Brien-Simpson et al. 2000; O'Brien-Simpson et al. 2009; Veith et al. 2014) .
Previous CP activity tests determining proteinase activity, latex bead agglutination, and presence of P. gingivalis by enzyme-linked immunosorbent assay (ELISA), DNA probes, and real-time polymerase chain reaction (PCR) have used subgingival plaque for analysis (Loesche et al. 1990; Loesche et al. 1992; Nisengard et al. 1992; Boyer et al. 1996; Eick and Pfister 2002) . These subgingival plaque-based assays have had limited success due to low specificity and/or sensitivity, long development times, or the requirement to send samples to a laboratory service for analysis that does not provide point-of-care utility. Saliva, regarded as a reservoir for oral bacteria, is an easy and noninvasive biological fluid to collect and is being investigated to aid in the detection of a range of diseases (Hu et al. 2008; Zhang et al. 2016 ). Real-time PCR has shown that the levels of P. gingivalis in saliva and subgingival plaque are closely associated and that these levels also correlate with disease prevalence, severity, or activity (Boutaga et al. 2007; Byrne et al. 2009; Saygun et al. 2011; He et al. 2012; Nomura et al. 2012) . Lateral-flow immunochromatographic-based assays are considered a gold standard in point-of-care diagnostics, being portable, fast, simple to use, and typically having high sensitivity, specificity, and accuracy (Ngom et al. 2010; Mohd Hanafiah et al. 2013) .
The aim of this study was to develop and evaluate an immunochromatographic device with A1-adhesin monoclonal antibodies (mAbs) to detect P. gingivalis in saliva as compared with real-time PCR detection of the bacterium in saliva and subgingival plaque as well as with clinical indices of disease in a case-control study.
Materials and Methods

Subjects, Ethics Approval, Clinical Examination, and Subgingival Plaque Sampling
This clinical study conformed to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for case-control studies (http://www.strobe-statement.org). Ethics approval was obtained from the University of Melbourne Health Sciences Human Ethics Subcommittee (approval 1136780). Fifty untreated subjects diagnosed with moderate to severe CP provided informed consent and were enrolled into the study from the periodontal clinic of the Royal Dental Hospital of Melbourne in 2012. At examination, the periodontal PDs at 6 sites per tooth were recorded with a Williams probe. PD, recession, CAL, BOP, and suppuration were recorded for each site. All CP subjects exhibited at least 1 pocket ≥5 mm in each quadrant and were classified as having moderate to severe disease based on CAL and PD measurements (Darby et al. 2000; Eke et al. 2012 ). The CP patients had >5% of sites that bled on gentle probing, clear radiographic evidence of bone loss, and an average modified gingival index ≥1, representative of at least mild inflammation at the papillary and marginal gingivae (Lobene et al. 1986 ). Exclusion criteria were as follows: periodontal treatment in the last 12 mo, antibiotics or anti-inflammatory drug therapy in the last 3 mo, smoking in the last 12 mo, any related systemic disease/ condition (e.g., diabetes), and individuals with <20 teeth. Patients were age and sex matched with control subjects from the staff and patients of the Royal Dental Hospital of Melbourne. The control subjects were clinically periodontally healthy, defined as having no PD >3 mm. The control subjects had <5% of sites that bled on gentle probing, no radiographic evidence of bone loss, and an modified gingival index <1, representative of an absence of inflammation at the papillary and marginal gingivae. The number of subjects (50 cases with 50 controls) was based on our previous work (Byrne et al. 2009 ). The sample size was calculated per comparisons of the prevalence of P. gingivalis-positive sites in progressing (diseased) and nonprogressing (healthy) subjects with G*Power 3.1 sample size package (http://www.psycho.uni-duesseldorf.de/abteilungen/ aap/gpower3/; Faul et al. 2007 ), based on a z test for comparing 2 independent proportions, an alpha value of 0.05, and a power value of 0.80. Subgingival plaque samples were taken with a sterile curette from the deepest 6 sites in each subject from the test and control groups. Each plaque sample was immediately placed into a coded tube containing 200 μL of TE buffer (10mM tris[hydroxymethyl]-methylamine chloride, 1mM EDTA) on ice and stored at −80 °C.
Bacterial Strains, Antigen, and mAb Preparation
The following methodology is described in the Appendix: bacterial culture and enumeration, purification of the RgpA-Kgp complexes; preparation of OMVs, formalin-killed P. gingivalis cells, recombinant A1-adhesin domains, and peptide epitope antigens (EAs); and mAb production.
ELISA, Plaque, and Saliva Bacterial DNA Extraction and Real-time PCR
ELISAs of P. gingivalis, bacterial DNA extraction of plaque and saliva samples, and real-time PCR were performed as described in the Appendix and in Appendix Table 1 .
Saliva Collection and Detection Device
A saliva sample was taken at the examination before any treatment was commenced. The detection device supplied by GC Corporation (Tokyo, Japan) consisted of 1) the test device containing A1-adhesin mAb-1, 2) treating solution (A1-adhesin mAb-2-conjugated gold particle), and 3) accessories (paraffin gum, cup, pipette, and a graduated mixing container). Subjects chewed the paraffin gum for 1 min and drooled into a coded plastic cup. Following this, 250 μL of saliva was placed in the mixing container and mixed with 100 μL of the treating solution for 10 s. The saliva/treating solution was then applied to the sample window of the test device by an analyst blind to the code, to minimize potential bias and the outcome, read at 90 s from application. The remainder of the saliva sample was stored at −80 °C for further analysis by real-time PCR. Photographs of the devices were taken with the FujiFilm Las 3000 imager (Fuji Photo Film Co.) with a standard 1/30-s exposure.
Statistical Analysis
All participants, samples, and data were coded, and the data were entered and locked before the code was released. SPSS 22 statistical software (SPSS Inc) was used for all statistical tests. All data were analyzed for homogeneity of variance with Levene's test. The level of statistical significance was set at α = 0.05. Comparisons of categorical and continuous data were made by chi-square and independent t tests, respectively. Categorical variables were as follows: test device outcomenegative and positive outcomes ascribed values of 0 and 1, respectively; periodontal health status-health and disease ascribed values of 0 and 1, respectively. Continuous variables were PD and PCR data for saliva and plaque samples. Correlations of nonparametric data were analyzed by Spearman's rank correlation. Correlations of categorical and continuous data were made by point-biserial correlation.
Results
Selection and Specificity of mAbs for the P. gingivalis Detection Device
Mice were immunized with recombinant A1 domain protein antigen (PA) and synthesized peptides (EA) representing sequences from the RgpA-Kgp complex to generate B-cell hybridomas. After initial B-cell hybridoma screening, 39 mAbs were selected for further screening and purified by protein A/G fast protein liquid chromatography (FPLC), concentrated, and purity assessed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) (Appendix Fig. 1 ). Figure 1A and Appendix Figures 2 and 3 show that 6 mAbs (PA1/1, PA2/2, EA1/4, EA1/6, EA3/4, EA5/7) had the highest affinities for formalin-killed P. gingivalis cells. With a titration of viable P. gingivalis cells as the adsorbed antigen, 3 mAbs (EA1/4, EA1/6, PA2/2) had the strongest binding, with detection limits of 6.5 × 10 3 , 6.5 × 10 3 , and 2.0 × 10 2 P. gingivalis cells, respectively ( Fig. 1B) . PA2/2 mAb was found to not cross-react with the EA1 peptide antigen (Fig. 1C ). Microbial flow cytometry showed that EA1/6 and PA2/2 mAbs bound viable P. gingivalis cells to a greater extent than EA1/4 mAb ( Fig. 2A ). EA1/6 and PA2/2 mAbs were found to bind all of the P. gingivalis-type strains tested and recognize only P. gingivalis cells in a panel of periodontal/oral bacteria ( Fig. 2B, C) . Hence, EA1/6 and PA2/2 mAbs were used in the manufacture of the P. gingivalis detection device.
Characterization and Specificity of the P. gingivalis Detection Device
To characterize the detection device, saliva free of P. gingivalis (undetectable by real-time PCR) was inoculated with different P. gingivalis strains. Initial trials found that the device gave a rapid detection response within a time range of 20 to 90 s and with some false positives from 180 s following saliva application. All detection device results were recorded at 90 s from saliva application in the characterization of the device and with the patient and control cohort study (below). The detection device was able to detect P. gingivalis W50, 381, and ATCC33277 at 5 × 10 4 cells/mL (Fig. 3A, Appendix Fig. 4 ) and 5 × 10 5 cells/mL of P. gingivalis A7A1-28 strain (Appendix Fig. 4) . We further inoculated saliva with the RgpA-Kgp complex and OMVs from P. gingivalis at proteinase activity levels equivalent to specific P. gingivalis whole-cell proteinase activity levels. The device was able to detect the RgpA-Kgp complex and OMVs at equivalent cell levels of 5 × 10 4 and 5 × 10 5 cells/mL, respectively (Appendix Fig. 5 ). With 5 × 10 5 cells/mL as a detection limit, Figure 3B shows that all P. gingivalis clinical isolates and laboratory strains tested were detected by the device.
Characterization of the Study Population
A total of 100 participants meeting inclusionary criteria were enrolled in the study, with 50 of these untreated but diagnosed with moderate to severe CP, who were matched for age and sex with 50 periodontally healthy participants. All participants provided a saliva sample and subgingival plaque samples and underwent a periodontal examination. As shown in Table 1 , there was a significant difference in the average CAL, BOP, and PD and percentage sites with 4-to 6-mm or >7-mm PDs in the CP group when compared with the healthy cohort. With realtime PCR as a standard analysis technique, the CP group had a greater prevalence of P. gingivalis in subgingival plaque and saliva than the control group (Table 1) . Furthermore, both the number of P. gingivalis cells/mL and the proportion of total bacteria were significantly (P < 0.001) higher in subgingival plaque and saliva of the CP group versus the control group (Table 1) .
Detection of P. gingivalis
Correlation between the Detection Device and Real-Time PCR in the Study Population. In evaluating the P. gingivalis detection device, we initially compared the levels of P. gingivalis in saliva and subgingival plaque using the real-time PCR data and then with clinical parameters. Significant (P < 0.01) positive correlations between saliva and subgingival plaque for the number of P. gingivalis cells/mL (r = 0.819) and for the proportion of total bacteria (r = 0.633) were found for the whole study group. In both saliva and subgingival plaque, the P. gingivalis cells/mL and the percentage of P. gingivalis of total bacteria were positively correlated with clinical indices of disease (Appendix Table 2 ). Of the CP group, 40 subjects tested positive for P. gingivalis by real-time PCR, and 39 subjects were positive based on the device. In the control group, 2 subjects tested positive for P. gingivalis by real-time PCR, and both were also positive based on the device. Figure 3C shows the outcomes of the saliva detection device for the CP subjects (T1 to T24), as well as the positive and negative outcomes representative of the whole study cohort. Based on point-biserial analysis, the positive and negative outcomes from the P. gingivalis detection device were compared with saliva and subgingival plaque via real-time PCR data and with clinical diagnosis (CP or control; Table 2 ). A positive correlation was found between the detection device result and the level of P. gingivalis cells/mL in saliva (r = 0.778, P < 0.001) and as a proportion of total bacteria in saliva (r = 0.715, P < 0.001). Furthermore, a positive correlation was found between the detection device result and the level of P. gingivalis in subgingival plaque (r = 0.771, P < 0.01) and the proportion of P. gingivalis of the total bacterial load in subgingival plaque (r = 0.746, P < 0.01). In saliva and subgingival plaque, a positive detection device outcome corresponded to >1 × 10 5 P. gingivalis cells/mL, whereas a negative outcome corresponded to <1 × 10 5 P. gingivalis cells/mL (Table 2) . Based on the threshold of 1 × 10 5 P. gingivalis cells/mL, the sensitivity, specificity, and positive and negative predictive values for the device were 95.0%, 93.3%, 90.5%, and 96.6%, respectively, with an accuracy of 94.0% for saliva, which was similar to the values based on subgingival plaque (Table 2) .
Correlation between the Detection Device and Clinical Indices and Diagnosis.
The detection device outcome was found to positively correlate with mean PD (r = 0.695, P < 0.01). In the CP group, the mean PD (r = 0.290, P < 0.05) and the percentage sites with 4-to 6-mm (r = 0.306, P < 0.05) and ≥7-mm pockets (r = 0.373, P < 0.01) significantly and positively correlated with the device result. In both the CP group and the control group, a positive device result corresponded to >1 × 10 5 P. gingivalis cells/ mL and >10% P. gingivalis of total bacteria in subgingival plaque, whereas a negative outcome corresponded to <1 × 10 5 P. gingivalis cells/mL and <10% P. gingivalis of total bacteria (Table 2) . For clinical diagnosis of disease, the P. gingivalis detection device had a sensitivity, specificity, and positive and negative predictive values of 81.3%, 94.0%, 92.9% and 83.9%, respectively, with an accuracy of 87.8%.
Discussion
Early detection and minimal intervention are key objectives in modern dentistry in the management of oral diseases. Recent microbiome analyses of subgingival plaque samples taken from patients with CP have confirmed the presence of P. gingivalis in microbiological communities associated with disease (Hong et al. 2015; Kirst et al. 2015) . Furthermore, intraoral levels of P. gingivalis have been shown to be predictive of periodontitis progression (i.e., disease activity; Byrne et al. 2009 ); hence, the chair-side assessment of P. gingivalis intraoral levels may assist in the early detection of disease risk. With use of mAbs to the A1-adhesin of P. gingivalis, a chair-side (point of care) immunochromatographic device has been developed for detection of P. gingivalis in saliva. The device exhibited a high level of sensitivity and specificity, with 94.0% accuracy in detecting P. gingivalis at a level >1 × 10 5 cells/mL. Furthermore, the device was found to have a 87.8% accuracy in confirming the clinical classification of CP status, which is superior to the reported 34.5% accuracy of diagnosing CP by dental graduates (Sajadi 2015) . The participants in the current study with CP had not received treatment in the previous 12 mo and so would be expected to exhibit a higher degree of disease activity (progression of attachment loss) as compared with the control participants, classified as periodontally healthy according to conventional clinical indices. This potential differential in disease activity between the 2 groups was reflected in the results obtained with the saliva P. gingivalis detection device. The use of saliva as the biological material for screening has obvious advantage, as sample collection is noninvasive, which facilitates rapid screening, as evidenced here with the whole procedure from sample collection to test outcome taking 3 min. A number of studies have suggested that saliva could be used for the detection of a variety of biomarkers that may assist in the diagnosis of CP (Saygun et al. 2011; Slots and Slots 2011; Ebersole et al. 2015; Izadi Borujeni et al. 2015) . In this study, we have shown that the level of P. gingivalis in saliva, either as cells/mL or as a proportion of total bacterial load, correlated with the levels of P. gingivalis in subgingival plaque, which corroborates earlier studies showing this close association (Boutaga et al. 2007; Saygun et al. 2011; He et al. 2012; Nomura et al. 2012) . Furthermore, the level of P. gingivalis in subgingival plaque has been positively associated with CP (Socransky et al. 1998; Darveau et al. 2012; Hong et al. 2015; Kirst et al. 2015) , and above threshold levels, it can predict disease progression (Byrne et al. 2009 ). A recent systematic meta-analysis of the literature reported moderate evidence that a consortium including P. gingivalis was associated with periimplantitis (Pérez-Chaparro et al. 2016 ). Hence, a chair-side detection device for P. gingivalis may have utility to assist in the determination of risk for both CP and peri-implantitis.
Earlier chair-side microbial-based tests for the screening of CP risk have included determining subgingival plaque levels of proteinase activity with N-benzoyl-DL-arginine-2-naphthylamide tests, agglutination of latex beads, and whole-cell bacterial ELISAs (Loesche et al. 1990; Nisengard et al. 1992; Boyer et al. 1996) . In the majority of these previous tests, a high sensitivity has come at the expense of specificity or vice versa (Boyer et al. 1996; Hemmings et al. 1997; Eick and Pfister 2002; Kaman et al. 2012) . This was found not to be the case for the current detection device, which had sensitivity and specificity values of 95.0% and 93.3%, respectively. Targeting the major and conserved antigen A1-adhesin domain of the P. gingivalis RgpA-Kgp complex resulted in the high sensitivity and specificity. The detection device recognized not only whole cells but also products that are released, such as OMVs and the RgpA-Kgp complex. Furthermore, the saliva detection device was able to recognize all of the P. gingivalis-type strains and clinical isolates with no appreciable/significant cross-reaction with other oral bacteria tested. A criticism of periodontitis screening assays/ devices has been that they do not distinguish between quiescent and active disease (Ji and Choi 2015). However, it has been shown that the composition of the microbiome of subgingival plaque-in particular, an increase in the level of P. gingivalis above threshold levels-is strongly associated with risk of active disease (i.e., progression of attachment loss; Byrne et al. 2009 ). By adjusting the mAb concentrations, the detection limit for the device was set to capture this threshold with clinical plaque and saliva samples. The detection threshold for the device was 1 × 10 5 P. gingivalis cells/mL in saliva.
Conclusion
A chair-side (point of care) P. gingivalis detection device was equivalent to that of real-time PCR in detection of P. gingivalis at levels reported to be associated with CP progression (disease activity; Byrne et al. 2009 ). With very high sensitivity, specificity, and accuracy, the P. gingivalis detection device may have utility as an adjunctive chair-side method for the assessment of risk for CP and peri-implantitis.
